期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

卵巢癌腹腔化疗 被引量：4

下载PDF
导出
摘要 卵巢癌的发病率位于女性生殖道恶性肿瘤的第3位,仅次于宫颈癌和宫体癌。卵巢癌不易早期诊断。5年生存率仅为10%～20%,由于卵巢癌具有独特的生物学特性,即使晚期卵巢癌,肿瘤仍局限于腹腔。随着对卵巢癌治疗的不断深入研究,腹腔化疗方法也在不断改进。对卵巢癌腹腔化疗的理论基础、临床应用及临床疗效进行综述。
作者 刘明艳 张虹
机构地区 天津医科大学 天津市中心妇产科医院
出处 《国外医学（计划生育．生殖健康分册）》 2007年第3期165-168,共4页
关键词 卵巢癌 腹腔 化疗
分类号 R737.31 [医药卫生—肿瘤]
  • 相关文献

参考文献21

  • 1Ozols RF. Challenges for chemotherapy in ovarian cancer[J]. Ann Oncol, 2006, 17[ Suppl 5]: 181-187.
  • 2Bristow RE, Tomacruz RS, Armstong DK, et al. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: ametaanalysis[J]. J Clin Oncol, 2002, 20(6): 1248-1259.
  • 3Jaaback K, Johnson N. Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer [J]. Cochrane Database Syst Rev, 2006, 25(1): 5340-5344.
  • 4Hamilton CA, Berek JS. Intraperitoneal chemotherapy for ovarian cancer[J]. Curr Opin Oncol, 2006, 18(5): 507-515.
  • 5Alhayki M, Hopkins L, Le T. Intraperitoneal chemotherapy for epithelial ovarian cancer[J]. Obstet Gynecol Surv, 2006, 61(8): 529-534.
  • 6Mohamed F , Sugarbaker PH . Intraperitoneal taxanes [J]. Surg Oncol Clin N Am, 2003, 12(3): 825-833.
  • 7Brown JV, Peters WA, Rettenmaler MA, et al. Three-consecutlveday topotecan is an active regimen for recurrent epithelial ovarian cancer[J]. Gynecol Oncol, 2003, 99(2): 136-140.
  • 8Gordon AN, Heagle JT, Guthrie D, et al. Recurrent epithelial ovarian carcinoma: a randomized phase study of pegylated liposomal doxorubicin versus topotecan[J]. J Clin Oncol, 2001, 19(14): 3312-3322.
  • 9Ozols RF, Markman M. Intraperitoneal chemotherapy for ovarian cancer[J]. N Engl J Med, 2006, 354(15): 1641-1643.
  • 10Fujiwara K, SakuragiN, Suzuki S, et al. First line intraperitoneal carboplatin based chemotherapy for165 patientswith epithelialovarian carcinoma: resultsof long term follow up [J]. Gynecol Oncol,2003, 90 (3) : 637-643.

同被引文献29

  • 1崔书中,巴明臣,唐鸿生.腹腔热灌注化疗技术方法变迁及展望[J].中华临床医师杂志（电子版）,2011,5(7):2039-2042. 被引量：36
  • 2张蓉,吴令英,张凯,李巍,孙阳春,罗京伟.晚期复发性卵巢癌热灌注化疗近期疗效探讨[J].临床肿瘤学杂志,2006,11(10):789-790. 被引量：27
  • 3Alhayki M, Hopkins L, Le T. Intraperitoneal chemotherapy for epithelial ovarian cancer [J] . Obstet Gyneeol Surv, 2006, 61 (8) : 529 - 534.
  • 4Carswell EA, Old LJ, Kassel RL, et al. An endotoxin-induced senirn factor that causes necrosis of tumors[J]. Proc Natl Acad Sci U S A, 1975,72 (9) : 3666 - 3670.
  • 5Fujiwara K, Markman M, Morgan M, et al. lntraperitoneal carhoplatin- based chemotherapy for epithelial ovarian cancer[ J ]. Gynecol Oncol, 2005,97( 1 ) : 10 - 15.
  • 6Watanabe N, Niitsu Y, Neda H, et al. Cytocidal mechanism of TNF: effects of lysosomal enzyme and hydroxyl radical inhibitors on cytotoxicity[ J ]. lmmunopharmacol hnmunotoxicol, 1988,10 (1 ) :109 - 116.
  • 7Sacchi A, Gasparri A, Gallo-Stampmo C,et al. Synergistic antitumor activity of cisplatin, paclitaxel, and gemcitabine with tumor vasculature-targeted tumor necrosis factor-alpha [ J ]. Clin Cancer Res,2006, 12(1 ) :175 - 182.
  • 8Kuroda K, Miyata K, Tsutsumi Y, et al. Preferential activity of wildtype and mutant tumor neerosis faetor-alpha against tumor-derived endothelial-like cells [ J ]. Jpn J Cancer Res, 2000,91 ( 1 ) : 59 - 67.
  • 9S-da E,Follana P,Peyrade F,et al. Pathogenesis and management of refractory malignant ascites [ J ]. Bull Cancer ,2011,98 (6) :679 - 687.
  • 10Jaaback K, Johnson N. lntraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer [ J ]. Cochrane Database Syst Rev ,2006, ( 1 ) :CD005340.

引证文献4

二级引证文献7

国外医学（计划生育．生殖健康分册）
2007年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部